Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Athersys Inc (NQ: ATHX )

1.770 USD +0.190 (+12.03%)
Official Closing Price Updated: 7:57 PM EST, Nov 25, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Athersys Inc

< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
4 Penny Stocks To Buy According To Analysts; 48%-463% Price Targets
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
12 Healthcare Stocks Moving In Wednesday's After-Market Session
Gainers Corcept Therapeutics (NASDAQ:CORT) shares rose 22.99% to $22.95 during Wednesday's after-market session. At the close, ... 
Tags Health Care ORTX STOK
From Benzinga
Athersys Announces Three Appointments to Board of Directors
Athersys announces three appointments to its board of directors, deepening board expertise to prepare for future growth and commercialization. 
From Business Wire News Releases
Athersys Reports Third Quarter 2020 Results and Provides Corporate Update
Athersys announces Q3 earnings and initiation of MultiStem® Phase 2 clinical trial in patients with trauma related inflammation and complications 
From Business Wire News Releases
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags bluebird bio inc/ MTCR HSDT
From Benzinga
Athersys to Host Third Quarter Financial Results Call
Athersys, Inc. (Nasdaq: ATHX) will release its third quarter 2020 financial results on Monday, November 9, 2020. 
From Business Wire News Releases
44 Stocks Moving In Wednesday's Mid-Day Session
Gainers Spi Energy Co Ltd (NASDAQ: SPI) shares climbed 718.5% to $8.43 after the company launched a new electric vehicle ... 
Tags DTEA ATHX TLRY
From Benzinga
Return On Capital Employed Overview: Athersys
During Q2, Athersys's (NASDAQ: ATHX) reported sales totaled $84.00 thousand. Despite a 16.36% in earnings, the company posted a loss ... 
Tags Market News Penny Stocks ATHX
From Benzinga
Thinking about buying stock in Athersys, Party City, AcelRx Pharmaceuticals, Southwest Airlines, or Carnival Corp?
InvestorsObserver issues critical PriceWatch Alerts for ATHX, PRTY, ACRX, LUV, and CCL. 
From PR Newswire
The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Biotech PCVX DBVT
From Benzinga
38 Stocks Moving in Wednesday's Pre-Market Session
Gainers Predictive Oncology Inc. (NASDAQ: POAI) shares rose 43.1% to $1.21 in pre-market trading after the company secured ... 
Tags AXU BZH Benzinga
From Benzinga
FDA Grants RMAT Designation to MultiStem Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome
MultiStem is the only cell therapy program for acute respiratory distress syndrome (ARDS) that has both Fast Track and RMAT designation from the FDA. 
From Business Wire News Releases
First Week of ATHX November 20th Options Trading
Investors in Athersys Inc (ATHX) saw new options become available this week, for the November 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATHX options... 
Tags Stocks
From Market News Video
The Math Shows XBI Can Go To $161
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Sum Up The Pieces: VHT Could Be Worth $228
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Athersys (ATHX) Q2 2020 Earnings Call Transcript
ATHX earnings call for the period ending June 30, 2020. 
Tags ATHX Market News
From Motley Fool
Athersys Reports Second Quarter 2020 Results
Athersys has made progress during Q2 in key clinical programs and infrastructure to support its planned transition to becoming a commercial company. 
From Business Wire News Releases
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive ... 
Tags FENC ORGO SWAV
From Benzinga
Block-Buster SAR-CoV2 Disrupters Pre-ICU / Admitted ICU Patient Treatments & COVID-19 T-Cell Vaccine Horizon
In recent months, there has been a flurry of activity within the clinical trial sector. When all trial types are considered, there are over 400 studies exploring approaches to diagnosing, treating, or... 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Market Briefing For Tuesday, July 21
Tuesday may be a bit skittish but we see this market moving higher even as the case counts do as well; and it's not incongruous as to how this battle rages both for humanity and the weapons to fight... 
Tags Technology ETFs Stocks / Equities
From Blogs - TalkMarkets
Athersys to Host Second Quarter Financial Results Call
Athersys, Inc. (Nasdaq: ATHX) will release its second quarter 2020 financial results on Monday, August 10, 2020. 
From Business Wire News Releases
First Week of ATHX September 18th Options Trading
Investors in Athersys Inc (ATHX) saw new options begin trading this week, for the September 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATHX options... 
Tags Stocks
From Market News Video
Analysts Anticipate PBSM To Hit $29
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
64 Biggest Movers From Yesterday
Gainers Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) shares jumped 135.3% to close at $7.30 after the company received FDA ... 
Tags Benzinga CRDF KERN
From Benzinga
Here's Why Athersys Stock Is Soaring Today
The stem cell stock jumped after a major Wall Street firm initiated coverage, but there's a catch. 
Tags ATHX Market News
From Motley Fool
Top Buys by Directors: Traub's $322.5K Bet on ATHX
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company... 
Tags Stocks
From Market News Video
46 Stocks Moving In Thursday's Mid-Day Session
Gainers Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) shares climbed 133% to $7.22 after the company received FDA clearance to ... 
Tags Market News NCTY CIH
From Benzinga
Afternoon Market Stats in 5 Minutes
Movers Indices • S&P 500 ETF (NYSE:SPY) fell 0.10% to $303.98. • Nasdaq ETF (NASDAQ:QQQ) increased 0.03% to ... 
Tags TLT Benzinga Markets
From Benzinga
Thursday's ETF Movers: XBI, EMLP
In trading on Thursday, the SPDR— S&P— Biotech ETF is outperforming other ETFs, up about 1.5% on the day. Components of that ETF showing particular strength include shares of Athersys, up about 26.8%... 
Tags ETFs
From ETF Channel
Thursday Sector Leaders: Grocery & Drug Stores, Biotechnology Stocks
In trading on Thursday, grocery & drug stores shares were relative leaders, up on the day by about 2%. Leading the group were shares of GNC Holdings, up about 28.2% and shares of Rite Aid up about... 
Tags Stocks
From Market News Video
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.